SYNOPSIS Enzyme assays in a series of 38 cases of pleural effusion and in 10 cases of ascites associated with malignant lesions and of 24 of pleural effusion and of five of ascites of benign origin do not support the suggestion that the estimation of the fluid lactate dehydrogenase serum ratios in pleural and peritoneal effusions is of value in the diagnosis of malignancy.
The original discoveries of Warburg (1913) indicated that cancer cells differ from normal cells in that their respiration is irreversibly impaired. The consequent lack of energy from this source is compensated for by an increase in anaerobic glycolysis. Little clinical diagnostic use had been made of this discovery until Hill and Levi (1954) and Hill (1955) showed that the activity of lactate dehydrogenase, the end enzyme in the glycolysis pathway, is raised in the serum of some patients with neoplastic disease. Hill (1956) later reported that sarcoma cells exhibit high activity of lactate dehydrogenase, and when suspended in isotonic saline solution contribute considerable activity to the fluid medium. In this respect they differ from erythrocytes which also possess high lactate dehydrogenase activity but which when similarly treated do not cause enzyme activity to appear in the salt solution.
On the basis of this work Wroblewski (1957) likened pleural and peritoneal fluids containing malignant cells to cultures of cancer cells in vivo and postulated that these cells would also contribute lactate dehydrogenase activity to the fluid surrounding them. He pointed out that under these circumstances one would expect serous effusions containing, or in contact with, malignant cells to have greater lactate dehydrogenase activity than that of the serum derived from the same individual, and conversely that activity in a non-malignant effusion would be less than that of the corresponding serum. The difference in activity between serum and effusion in the same individual was explained as being due to the globulin nature of lactate dehydrogenase, which does not readily pass serous membranes. Although he produced a series of cases in Received for publication 22 September 1961. support of this hypothesis, Wr6blewski observed that 'considerable extension of the study of lactate dehydrogenase activity and other enzymes of serous effusions is necessary before a definitive conclusion can be reached regarding the reliability of the chemical technique for the characterization of effusion as either benign or malignant'.
Our work was begun late in 1958 as a contribution to this study, and we record our results in the present communication.
METHODS AND MATERIALS
Lactate dehydrogenase (King, 1959; 1960b) , malate dehydrogenase (King, 1961) , glutamate-oxalacetate transaminase (GO-T), glutamate-pyruvate transaminase (GP-T) (King, 1960a) , and alkaline phosphatase (King and Wootton, 1956) were estimated by colorimetric procedures. Lactate dehydrogenase assays were invariably carried out in duplicate and on numerous occasions repeat estimations were performed, not only where results for fluid and serum were similar but as checks on the stability of the enzyme. This was necessary because on some occasions it was not practicable to undertake enzyme assays until several days after the specimens were obtained. Fluids from pleural and peritoneal effusions were obtained by the usual methods of paracentesis and the sera by venepuncture within the same hour. All haemolysed specimens were excluded from the study, and also fluids which were not considered to be effusions in the true sense. In the latter category were a chylous pleural effusion and a peritoneal fluid which was found to be the contents of a ruptured ovarian cyst.
Most specimens were obtained from patients in the Barrow and Furness group of hospitals, but a number were submitted by the kindness of physicians 57 from other hospital groups in Lancashire who knew of our interest in this subject.
The question of including serial specimens from the same patient was considered but it was observed that the relationship between the lactate dehydrogenase of serum and effusion tended to remain constant for each individual. Under these circumstances it is clear that an investigator could weigh his results as desired by including in his series numerous estimations from suitable cases. In order to eliminate this source of criticism only the first assay is included from any individual. With this provision and the few exceptions previously noted, all specimens received were included in the series and there was no further selection.
With reach a conclusion based upon histology, and in fact in only two such cases were radiological criteria alone used. In all cases of malignant ascites, tumour cells were found in the fluid or macroscopic evidence of tumour was seen at laparotomy. Finally, it is known that every patient included in the malignant series is now dead. It must be admitted that the diagnosis of benign effusions may lack the precision possible in the case of malignant ones. This is because in self-limiting and transitory disorders it is usually necessary to rely on clinical assessment and radiological and bacteriological methods rather than histology. Nevertheless, the identification of the benign nature of cases in these series, using generally accepted diagnostic criteria, has been on the whole successful, since of all such patients only four have died, two group.bmj.com on May 29, 2017 -Published by http://jcp.bmj.com/ Downloaded from from cirrhosis of the liver and two from heart failure.
RESULTS
The results of all enzyme assays are expressed in international units (King and Campbell, 1961) . However, for present purposes only the ratio of fluid enzyme activity to serum enzyme activity is important and this will be referred to subsequently as 'the ratio'. When this ratio is greater than unity, that is, the fluid activity exceeds the serum activity, the ratio may be said to be 'positive' and the pattern 'malignant'.
The series has been divided into pleural and ascitic effusions and further subdivided into malignant and benign lesions. The results obtained in the study for each group are presented in detail in Tables I to IV. LACTATE DEHYDROGENASE ESTIMATIONS In the first group (Table I) there are 38 cases of malignant pleural effusion. In 18 of these the serum lactate dehydrogenase activity exceeded that which is considered normal (70 to 230 i.u.) and in 25 the ratio was positive. There is no correlation between raised serum lactate dehydrogenase activity, and a positive ratio. Three fluids which were cytologically malignant exhibited an activity less than that of the corresponding serum.
In the group of benign pleural effusions (Table II) There are only five cases of benign ascites in this series and these are detailed in Table IV . Two had increased serum lactate dehydrogenase activity and only one gave a positive ratio.
OTHER ENZYMES In 70 cases GP-T assays were performed and in 58 cases the alkaline phosphatase was estimated. In every one of these the serum enzyme activity was greater than the fluid enzyme activity for all four groups. The GO-T ratio was determined in 72 cases in all; the 35 malignant pleural effusions and four benign ascitic fluids so assayed gave negative ratios. One synpneumonic pleural effusion and one case of empyema gave a positive ratio and three of the nine cases of malignant ascites in which this enzyme was determined also had a ratio greater than unity. These three cases were all cytologically malignant.
Malate dehydrogenase was assayed in the effusion fluid and serum of 58 cases in this series and in every ILE Finally, Jagt and Larsen in 1960 studied 53 patients with ascites, and in 51 % of 35 malignant cases found that the lactate dehydrogenase activity in the fluid exceeded that in the serum. Forty-five per cent of these fluids contained malignant cells. Curiously enough there was little relationship between the two groups with only 5 % overlap. The two methods together gave a positive diagnosis in 77 % of cases of malignant fluids. In 18 benign fluids all had fluid lactate dehydrogenase values less than serum, and they thought that this absence of false positives might he due to the lack of inflammatory aetiology in ascites. They mention in passing that they have studied lactate dehydrogenase activity in pleural effusions and that in general inflammatory effusions tend to give a lactate dehydrogenase ratio greater than 1. Their conclusion is that a ratio of more than 1 suggests that an ascitic fluid is malignant whereas a ratio lower than 1 does not rule out malignancy.
The results of the present study, which show onethird false negatives in both malignant pleural effusions and ascites, including four cases where neoplastic cells were present in the fluid, are in agreement with the figures reported by Kirkeby and Prydz (1959 
CONCLUSIONS
Most malignant and inflammatory benign effusions exhibit a higher lactate dehydrogenase activity than the corresponding blood plasma.
The presence or absence of neoplastic cells in the effusion fluid does not correlate with its lactate dehydrogenase activity nor with the fluid/serum enzyme activity ratio.
Such transudates as have been studied have given low fluid/serum ratios.
The assay of lactate dehydrogenase activity of effusions has no value in the diagnosis of malignancy.
